RNN: Rexahn Pharmaceuticals Corp
Recent Range: $1.25/share - $3.50/share (Current Price: 2.50, as of close of 4/20/10)
Price/Sales (P/S) = 2782.05 (1002.08, Industry)
Price/Book (P/B) = 25.22 (6.16)
Gross Margin = Not Available
Pre-Tax Margin = -8,516.6% (-4,752.1%)
Debt/Equity Ratio = 0.00 (0.36)
Current Ratio = 9.9 (6.0)
Return on Equity = -118.2% (-8.1%)
Return on Assets = -90.6% (-20.9%)
Analysis: This is not one of those “sure bets,” unless you mean a sure bet to lose.
